| P50 | author | Luisa Politano | Q87600676 |
| | Anna Rago | Q88828450 |
| | Gerardo Nigro | Q90410577 |
| | Alberto Palladino | Q123199852 |
| P2093 | author name string | Vincenzo Russo | |
| | Chiara Orsini | |
| | Salvatore Morra | |
| | Manuela Ergoli | |
| | Andrea A Papa | |
| P2860 | cites work | Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types | Q28378093 |
| | Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects | Q33160368 |
| | Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series | Q33747913 |
| | Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials | Q33750390 |
| | Dystrophin and mutations: one gene, several proteins, multiple phenotypes | Q34278933 |
| | Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure | Q34321811 |
| | The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 |
| | The heart in human dystrophinopathies | Q35067344 |
| | Forced expression of dystrophin deletion constructs reveals structure-function correlations. | Q36237129 |
| | Dystrophin protects the sarcolemma from stresses developed during muscle contraction | Q36259954 |
| | Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients | Q36334428 |
| | Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy | Q36877691 |
| | Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies | Q37276061 |
| | Familial dilated cardiomyopathy secondary to dystrophin splice site mutation | Q37703755 |
| | Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: Safety and risks | Q38388854 |
| | The implantable cardioverter-defibrillator: An update | Q38442118 |
| | Relation of Cardiac Dysfunction to Rhythm Abnormalities in Patients With Duchenne or Becker Muscular Dystrophies. | Q38764657 |
| | Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy | Q39166732 |
| | Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials? | Q40518954 |
| | The role of implantable cardioverter defibrillators in dilated cardiomyopathy | Q40741712 |
| | Dystrophin and its isoforms | Q41160193 |
| | Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation | Q41510408 |
| | Implantable cardiac defibrillator infections: the emerging importance of Mycobacterium fortuitum. | Q41996319 |
| | Presence of mechanical dyssynchrony in Duchenne muscular dystrophy | Q42615657 |
| | Pacemaker implantation for sinus node dysfunction in a young patient with Duchenne muscular dystrophy. | Q43014925 |
| | Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy | Q44249576 |
| | Successful cardiac resynchronisation therapy in Duchenne muscular dystrophy: a 5-year follow-up. | Q44785683 |
| | The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure | Q44803680 |
| | Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database. | Q45874288 |
| | Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. | Q46532286 |
| | Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis. | Q47179512 |
| | Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. | Q50870071 |
| | The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing. | Q51055280 |
| | Cardiac-resynchronization therapy for the prevention of heart-failure events. | Q51136225 |
| | Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging. | Q51356574 |
| | Life-threatening Arrhythmias in a Becker Muscular Dystrophy Family due to the Duplication of Exons 3-4 of the Dystrophin Gene. | Q51568549 |
| | Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. | Q53427444 |
| | Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. | Q53492924 |
| | Pectoralis blocks for insertion of an implantable cardioverter defibrillator in two patients with Duchenne muscular dystrophy. | Q54941612 |
| | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | Q55983200 |
| | Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex | Q57298863 |
| | Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy | Q57456679 |
| | Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies | Q58052218 |
| | Mutation of dystrophin gene and cardiomyopathy | Q58052236 |
| | Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature | Q64060853 |
| | Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety | Q64118435 |
| | [A case of pacemaker implantation for complete atrioventricular block associated with Duchenne muscular dystrophy] | Q73933400 |
| | Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation | Q78616932 |
| | Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography | Q79425792 |
| | Cardiac resynchronization therapy to prevent life-threatening arrhythmias in patients with congestive heart failure | Q82142120 |
| | [Complete atrioventricular block in Duchenne muscular dystrophy] | Q84991695 |
| | Cardiac asynchrony in Duchenne muscular dystrophy | Q86694970 |
| | Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies | Q91141431 |
| | Characteristic of fibrotic myocardial lesions associated with life-threatening ventricular tachyarrhythmias in patients with ischemic and non-ischemic cardiomyopathies | Q91286494 |
| | Cardiac resynchronization therapy in becker muscular dystrophy | Q95545314 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P433 | issue | 1 | |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| | muscular dystrophy | Q1137767 |
| | implanted electrodes | Q73401942 |
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Acta Myologica | Q15752538 |
| P1476 | title | Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results | |
| P478 | volume | 38 | |